ArticlePloS one2022
Acceptance rate and risk perception towards the COVID-19 vaccine in Botswana.
Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Equitable access to COVID-19 vaccines in Botswana: a scoping review.Frontiers in health services · 2025Pooled it
- Global COVID-19 vaccine acceptance rate: Systematic review and meta-analysis.Frontiers in public health · 2022Pooled it
- COVID-19 vaccine acceptance and associated factors in 13 African countries: A systematic review and meta-analysis.Frontiers in public health · 2022Pooled it
- A systems approach to understanding mechanisms underlying immunisation barriers: a participatory design study in Tanzania.BMJ global health · 2026Article
- COVID-19 vaccine acceptability and determinants of hesitancy among adults in Lagos, Nigeria.BMC public health · 2026Article
- Persistence to Adjuvant Endocrine Therapy for Breast Cancer in Botswana: An Observational Cohort Analysis.Breast care (Basel, Switzerland) · 2025Article
- Factors associated with COVID-19 vaccine uptake and hesitancy among women of reproductive age in Mozambique.Frontiers in public health · 2025Article
- What factors affect acceptance attitudes towards vaccination amidst a major public health crisis? A national cross-sectional study.BMJ open · 2024Article
- "Using behavioral insights to inform the COVID-19 vaccine response in KosovoPEC innovation · 2024Article
- Factors associated with full COVID-19 vaccination among persons living with diabetes mellitus in Uganda-A cross-sectional study.BMC public health · 2024Article
- Factors associated with COVID-19 vaccine receipt among mobile phone users in Malawi: Findings from a national mobile-based syndromic surveillance survey, July 2021-April 2022.PLOS global public health · 2024Article
- Gendered (SDG5) and other perspectives on COVID-19 vaccination status: a focus on South Africa's Limpopo province.Frontiers in global women's health · 2024Article
- Factors Influencing the Intention and Uptake of COVID-19 Vaccines on the African Continent: A Scoping Review.Vaccines · 2023Article
- Investigating Attitudes, Motivations and Key Influencers for COVID-19 Vaccination Uptake among Late Adopters in Urban Zimbabwe.Vaccines · 2023Article
- COVID-19 vaccine acceptance in sub-Saharan African countries: A systematic review and meta-analysis.Heliyon · 2023Review
- COVID-19 vaccine hesitancy among pregnant women in an antenatal clinic in Durban, South Africa.Southern African journal of infectious diseases · 2023Article
- The impact of age structure and vaccine prioritization on COVID-19 in West Africa.Infectious Disease Modelling · 2022Article
- Review
- Article
- Global Prevalence and Potential Influencing Factors of COVID-19 Vaccination Hesitancy: A Meta-Analysis.Vaccines · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe COVID-19 disease burden continues to be high worldwide and vaccines continue to be developed to help combat the pandemic. Acceptance and risk perception for COVID-19 vaccines is unknown in Botswana despite the government's decision to roll out the vaccine nationally.
objectivesThis study aims to assess the acceptance rate and risk perception of COVID-19 vaccines amongst the general population in Botswana.
methodsWe interviewed 5300 adults in Botswana from 1-28 February 2021 using self-administered questionnaires. The main outcomes of the study were vaccine acceptance and hesitancy rates. Demographic, experiential and socio-cultural factors were explored for their association with outcome variables.
resultsTwo-thirds of the participants were females (3199), with those aged 24-54 making the highest proportion (61%). The acceptance rate of COVID-19 vaccine was 73.4% (95% CI: 72.2%-74.6%) with vaccine hesitancy at 31.3% (95% CI: 30.0%-32.6%). When the dependent variable was vaccine acceptance, males had higher odds of accepting the vaccine compared to females (OR = 1.2, 95% CI: 1.0, 1.4). Individuals aged 55-64 had high odds of accepting the vaccine compared to those aged 65 and above (OR = 1.2, 95% CI: 0.6, 2.5). The odds of accepting the vaccine for someone with primary school education were about 2.5 times that of an individual with post graduate level of education. Finally, individuals with comorbidities had higher odds (OR = 1.2, 95% CI: 1.0, 1.5) of accepting the vaccine compared to those without any underlying conditions.
conclusionThis study demonstrated a high acceptance rate for the COVID-19 vaccine and a low risk perception in Botswana. In order to achieve a high vaccine coverage and ensure a successful vaccination process, there is need to target populations with high vaccine hesitancy rates. A qualitative study to assess the factors associated with vaccine acceptance and hesitancy is recommended to provide an in-depth analysis of the findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.